| Literature DB >> 33477980 |
Bretislav Lipovy1,2, Jakub Holoubek1, Marketa Hanslianova3, Michaela Cvanova4, Leo Klein5,6, Ivana Grossova7, Robert Zajicek7, Peter Bukovcan8, Jan Koller8, Matus Baran9, Peter Lengyel9, Lukas Eimer10, Marie Jandova11, Milan Kostal12, Pavel Brychta1, Petra Borilova Linhartova13,14,15,16,17.
Abstract
Toxic epidermal necrolysis (TEN) is a rare disease, which predominantly manifests as damage to the skin and mucosa. Antibiotics count among the most common triggers of this hypersensitive reaction. Patients with TEN are highly susceptible to infectious complications due to the loss of protective barriers and immunosuppressant therapy. The aim of this study was to investigate the potential relationship between antibiotics used before the development of TEN and early and late-onset infectious complications in TEN patients. In this European multicentric retrospective study (Central European Lyell syndrome: therapeutic evaluation (CELESTE)), records showed that 18 patients with TEN used antibiotics (mostly aminopenicillins) before the disease development (group 1), while in 21 patients, TEN was triggered by another factor (group 2). The incidence of late-onset infectious complications (5 or more days after the transfer to the hospital) caused by Gram-positive bacteria (especially by Enterococcus faecalis/faecium) was significantly higher in group 1 than in group 2 (82.4% vs. 35.0%, p = 0.007/p corr = 0.014) while no statistically significant difference was observed between groups of patients with infection caused by Gram-negative bacteria, yeasts, and filamentous fungi (p > 0.05). Patients with post-antibiotic development of TEN are critically predisposed to late-onset infectious complications caused by Gram-positive bacteria, which may result from the dissemination of these bacteria from the primary focus.Entities:
Keywords: antibiotics; early-onset infection; infectious complication; late-onset infection; toxic epidermal necrolysis
Year: 2021 PMID: 33477980 PMCID: PMC7835845 DOI: 10.3390/microorganisms9010202
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607